BCAX

Bicara Therapeutics Inc.

NasdaqGM · Healthcare

$29.20

+0.76% today

Price

hover · 4 moves explained

1 buy38 sells8 8-K

Analyst consensus

Buy

$31.46target+7.7%vs $29.20 today

$16.00 low today target$46.00 high

13 analysts · ~12-month consensus · as of May 28. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-05-26	Hyep Ivan	Chief Financial Officer	—Direct	9,200	$20.42	$187.9K
Exercise	2026-05-26	Hyep Ivan	Chief Financial Officer	—Direct	9,200	$3.79	$34.9K
Sell	2026-05-20	Mazumdar Claire	Chief Executive Officer	—Direct	2,978	$20.35	$60.6K
Sell	2026-05-20	Mazumdar Claire	Chief Executive Officer	—Direct	12,022	$19.96	$240.0K
Exercise	2026-05-20	Mazumdar Claire	Chief Executive Officer	—Direct	15,000	$3.79	$56.8K

Sell

Hyep Ivan

Chief Financial Officer · 2026-05-26

$187.9K

9,200 @ $20.42

Exercise

Hyep Ivan

Chief Financial Officer · 2026-05-26

$34.9K

9,200 @ $3.79

Sell

Mazumdar Claire

Chief Executive Officer · 2026-05-20

$60.6K

2,978 @ $20.35

Sell

Mazumdar Claire

Chief Executive Officer · 2026-05-20

$240.0K

12,022 @ $19.96

Exercise

Mazumdar Claire

Chief Executive Officer · 2026-05-20

$56.8K

15,000 @ $3.79

65 more transactions on ProFull insider transaction history is a Pro feature.